Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

BACKGROUND: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617509/
https://www.ncbi.nlm.nih.gov/pubmed/31128924
http://dx.doi.org/10.1016/S0140-6736(19)30840-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617509/
https://www.ncbi.nlm.nih.gov/pubmed/31128924
http://dx.doi.org/10.1016/S0140-6736(19)30840-2

Ejemplares similares